At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MAIA MAIA Biotechnology Inc.
Closed 11-14 16:00:00 EST
2.13
-0.26
-10.88%
盘后2.13
+0.00-0.05%
19:31 EST
High2.38
Low2.11
Vol240.76K
Open2.36
D1 Closing2.39
Amplitude11.26%
Mkt Cap51.05M
Tradable Cap41.72M
Total Shares23.97M
T/O527.98K
T/O Rate1.23%
Tradable Shares19.59M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BUZZ-U.S. STOCKS ON THE MOVE-Aramark, Pinterest, Lincoln Educational Services
Maia Biotechnology Announces Late-Breaking Abstract of Thio-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39TH Annual Meeting
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.